Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InspireMD (NSPR) Equity Average (2016 - 2025)

Historic Equity Average for InspireMD (NSPR) over the last 15 years, with Q3 2025 value amounting to $42.2 million.

  • InspireMD's Equity Average fell 426.38% to $42.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.2 million, marking a year-over-year decrease of 426.38%. This contributed to the annual value of $37.8 million for FY2024, which is 3285.58% up from last year.
  • Latest data reveals that InspireMD reported Equity Average of $42.2 million as of Q3 2025, which was down 426.38% from $24.3 million recorded in Q2 2025.
  • Over the past 5 years, InspireMD's Equity Average peaked at $45.0 million during Q3 2023, and registered a low of $15.4 million during Q1 2023.
  • Moreover, its 5-year median value for Equity Average was $35.3 million (2021), whereas its average is $33.6 million.
  • In the last 5 years, InspireMD's Equity Average soared by 53337.47% in 2021 and then plummeted by 5126.35% in 2023.
  • InspireMD's Equity Average (Quarter) stood at $35.3 million in 2021, then plummeted by 44.38% to $19.6 million in 2022, then surged by 110.78% to $41.4 million in 2023, then dropped by 6.43% to $38.7 million in 2024, then rose by 8.94% to $42.2 million in 2025.
  • Its Equity Average stands at $42.2 million for Q3 2025, versus $24.3 million for Q2 2025 and $32.2 million for Q1 2025.